IC Surgical, Inc.
Medical technology company developing an internal negative-pressure wound control system consisting of an implantable multibranched internal conduit (manifold) and single-use portable therapy units. The company has conducted preclinical and clinical studies, maintains a patent portfolio, and is pursuing phased commercialization across plastic and general surgery indications.
Industries
Nr. of Employees
small (1-50)
Patents
Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing
US-10695469-B2
View Details
Assemblies, systems, and methods for vacuum assisted internal drainage during wound healing
US-10695469-B2
View DetailsProducts
Internal negative-pressure wound control system (manifold + therapy unit)
A combined system comprising an implantable multibranched internal manifold conduit and single-use portable therapy units designed to apply continuous negative pressure to internal tissue planes and remove fluid postoperatively; supplied as configurable surgical kits.
Internal negative-pressure wound control system (manifold + therapy unit)
A combined system comprising an implantable multibranched internal manifold conduit and single-use portable therapy units designed to apply continuous negative pressure to internal tissue planes and remove fluid postoperatively; supplied as configurable surgical kits.
Services
Provision of downloadable clinician and patient instructional materials, user guides, and educational videos to support device use and patient self-care.
Commercial ordering support and product information for hospital and clinic customers, including configurable perioperative kits and therapy unit packs.
Provision of downloadable clinician and patient instructional materials, user guides, and educational videos to support device use and patient self-care.
Commercial ordering support and product information for hospital and clinic customers, including configurable perioperative kits and therapy unit packs.
Expertise Areas
- Internal negative-pressure wound therapy
- Clinical trial design and execution (pilot and retrospective studies)
- Preclinical animal model studies (porcine)
- Medical device design and system integration
Key Technologies
- Internal negative-pressure wound therapy
- Multibranched internal manifold conduits
- Single-use portable suction devices
- One-way connector mechanisms
News & Updates
Retrospective comparative study reporting statistically significant reductions in seroma, flap revision, any complication, and duration of therapy versus standard drains in prepectoral breast reconstruction (reported n=170 vs n=166 breasts).
Prospective pilot clinical study (n=24) evaluating safety and functionality of the internal negative-pressure system in abdominoplasty with no clinical seromas or device malfunctions reported through 30 days.
Clinical imaging evaluation using high-resolution ultrasound to assess internal tissue closure without fluid collection.
Independent publication reporting significant reductions in seroma and other complications versus standard drains in breast reconstruction patients.
24-patient pilot study in abdominoplasty demonstrating absence of clinical seroma and no device-related adverse events through 30 days.
Retrospective comparative study reporting statistically significant reductions in seroma, flap revision, any complication, and duration of therapy versus standard drains in prepectoral breast reconstruction (reported n=170 vs n=166 breasts).
Prospective pilot clinical study (n=24) evaluating safety and functionality of the internal negative-pressure system in abdominoplasty with no clinical seromas or device malfunctions reported through 30 days.
Clinical imaging evaluation using high-resolution ultrasound to assess internal tissue closure without fluid collection.
Independent publication reporting significant reductions in seroma and other complications versus standard drains in breast reconstruction patients.
24-patient pilot study in abdominoplasty demonstrating absence of clinical seroma and no device-related adverse events through 30 days.